Navigation Links
Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

tivity and impulsivity in children aged 6 to 17 years previously diagnosed with ADHD, as measured by several standardized tests when compared to placebo treatment.

In the two short-term trials, the primary endpoint was a reduction in ADHD symptoms as measured by the ADHD Rating Scale (ADHD-RS-IV). ADHD-RS-IV is a standardized, validated test for assessing symptoms of ADHD in children and for assessing their response to treatment. This scale, which contains 18 items, is based on the ADHD diagnostic criteria as defined in the APA's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision(R).

In the first trial, 301, investigators compared 2 mg, 3 mg or 4 mg GXR doses to placebo during an eight-week treatment period. The participants randomized to GXR all began at the 1 mg dose. At weekly visits, doses were titrated in 1 mg increments over the first four weeks to achieve the randomized dose. Then, doses were tapered down weekly so that all participants randomized to GXR received the 1 mg dose at week eight.

Participants achieved overall significant mean reductions from baseline in ADHD-RS-IV total scores by study end, -16.7 points vs. -8.9 for placebo (P <.0001). Investigators observed improvement in ADHD-RS-IV scores as early as two weeks after dosing began, with significant improvement in all GXR dose groups occurring at the third week.

Effect sizes, calculated using results from the ADHD-RS-IV scores and evaluated using weight-adjusted actual doses, were 0.44 (0.01 to 0.04 mg/kg), 0.58 (0.05 to 0.08 mg/kg), 1.19 (0.09 to 0.12 mg/kg), and 1.34 (0.13 to 0.17 mg/kg). In general, effect sizes are categorized as small (0.2), medium (0.5) and large (0.8).

In the second short-term trial, 304, investigators examined 1 mg, 2 mg, 3 mg and 4 mg doses and placebo during nine weeks of treatment. During the first three weeks, patients started at 1 mg with doses escalating in once- weekly 1 mg increments to achieve the
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), ... innovative HIV/AIDS vaccines, announced today the opening of a ... Clinic (AVRC) of the University of Alabama at Birmingham ... Although the GeoVax vaccines are currently being tested clinically ...
... MOUNTAIN VIEW, Calif., Feb. 9, 2011 Concentric Medical, Inc. ... 2 ( T hrombectomy RE vascularization of large ... University in Portland, Oregon and at Capital Health in Trenton, ... in TREVO 2 and Capital Health was first to use ...
Cached Medicine Technology:GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 3Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 2Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 3
(Date:5/25/2013)... Angeles, CA (PRWEB) May 25, 2013 IBISWorld ... will grow at an average annual rate of 28.7% to ... of 17.9% in 2013. From 2002 and 2008, no new ... Kevin Culbert, causing relatively modest growth during that period. In ... has approved six new products. This factor contributed to the ...
(Date:5/25/2013)... Virginia (PRWEB) May 25, 2013 Superior ... that relieves pain in seconds for arthritis, tendinitis and ... in alternative pain relief products announced a magnetic ... The magnetic bracelet for pain relief is demonstrated at ... pain uses 5400 Gauss magnets and has customers often ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 AdvantaClean of ... these key services for a healthy home and business ... water damage , mold inspections, mold testing, ... vent cleaning and coil cleaning. , With over 120 ... light environmental industry offering a full suite of services ...
(Date:5/24/2013)... 2013 myMEDholiday.com, a popular medical tourism ... in five important medical travel destinations in Asia, has ... to ensure a safe and successful trip for ... manual offers tips on cost-savings, how to find the ... and a wealth other essential advice. , A top-level ...
(Date:5/24/2013)... Before you start the grill, before you watch the game, kick ... Hoda Kotb on the Today Show on Memorial Day. Carley ... Lee and Hoda, including the new LawnBott® LB75 robotic mower. ... the military who made the ultimate sacrifice for us. On ... and family and enjoy the day. With a LawnBott® robotic ...
Breaking Medicine News(10 mins):Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4Health News:myMEDholiday.com Introduces International Patient Guide to Assist People Planning Treatment Abroad 2Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2
... yesterday that a Walkers crisps advertising campaign had made ... to the industry watchdog a promotional mailing saying Walkers ... of your guideline daily amount" was misleading considering the ... Walkers crisps. They have instructed Walkers to ensure that ...
... will now deliver healthcare at the doorstep of Jharkhand villagers.// ... because they are the ones who visit the remotest parts ... ,From delivering letters to Assam tea to anti-malaria medicines, ... day. ,According to an estimate of the ...
... that share many characteristics with normal stem cells propel ... blood vessel// formation, and may hold the key to ... the August 15th issue of Cancer Research. ... Preston Robert Tisch Brain Tumor Center at Duke University, ...
... Despite advances in surgery and chemotherapy, ovarian cancer is still ... leading cause of cancer death among women// in the United ... for ovarian cancer have remained stubbornly low because symptoms are ... a cost-effective, reliable test to diagnose this “silent killer” early, ...
... Department of Health to find the response time of ambulance ... failed to record correct details for how they responded to ... Government has set a target saying 75 per cent of ... minutes. Data collected by the Information Center for Health ...
... Michigan Depression Center, most of the pregnant women with severe ... with the risk of depression or showing signs of milder ... Psychiatry, the researchers conclude that even those who are getting ... adequate treatment -- medication, talk therapy, or both together -- ...
Cached Medicine News:Health News:Cancer Stem Cells Could Hold Key to Brain Tumor Therapy 2Health News:New Approach to Early Detection of Ovarian Cancer 2Health News:Incorrect Recording Of Response Time By Six Ambulance Trusts 2Health News:No therapy for most of the pregnant women with depression 2Health News:No therapy for most of the pregnant women with depression 3Health News:No therapy for most of the pregnant women with depression 4
Standard arthroscope with telescope (4 mm) for large joints....
... BN ProSpec, the system of choice for ... assays in medium throughput laboratories in more ... new milestone. Dade Behring is pleased to ... ProSpec system., ,The customer centered development ...
... OSCAR ulitizes ultrasonic waves to remove bone ... of the probe liquifies the cement at the ... in minutes. , ,A special feature of the ... contact and to signal this to the operator ...
The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....
Medicine Products: